Hinrichs, Gitte Rye by unknown
Syddansk Universitet
A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads
to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2
Hinrichs, Gitte Rye; Houlberg Hansen, Louise; Nielsen, Maria Ravn; Fagerberg, Christina








Publisher's PDF, also known as Version of record
Citation for pulished version (APA):
Hinrichs, G. R., Houlberg Hansen, L., Nielsen, M. R., Fagerberg, C., Dieperink, H., Rittig, S., & Jensen, B. L.
(2016). A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic
diabetes insipidus and attenuated urine exosome aquaporin-2. Physiological Reports, 4(8), [e12764]. DOI:
10.14814/phy2.12764
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 15. okt.. 2017
CASE REPORT
A novel mutation affecting the arginine-137 residue of
AVPR2 in dizygous twins leads to nephrogenic diabetes
insipidus and attenuated urine exosome aquaporin-2
Gitte R. Hinrichs1, Louise H. Hansen2, Maria R. Nielsen1, Christina Fagerberg3, Hans Dieperink4,
Søren Rittig5 & Boye L. Jensen1
1 Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
2 Anaesthesiology and Intensive Care, Odense University Hospital, Odense, Denmark
3 Clinical Genetics, Odense University Hospital, Odense, Denmark
4 Department of Nephrology, Odense University Hospital, Odense, Denmark
5 Department of Paediatrics, Aarhus University Hospital, Aarhus, Denmark
Keywords
ALIX, dehydration, receptor, vasopressin.
Correspondence
Gitte R. Hinrichs, Department of
Cardiovascular and Renal Research, Institute
of Molecular Medicine, University of
Southern Denmark, J. B. Winsløws Vej 21, 3,
DK-5000 Odense, Denmark.
Tel: +45 6550 3796
Fax: +45 6613 3479
E-mail: ghinrichs@health.sdu.dk
Funding Information
No funding information provided.
Received: 17 December 2015; Revised: 26
February 2016; Accepted: 21 March 2016
doi: 10.14814/phy2.12764
Physiol Rep, 4 (8), 2016, e12764, doi:
10.14814/phy2.12764
Abstract
Mutations in the vasopressin V2 receptor gene AVPR2 may cause X-linked
nephrogenic diabetes insipidus by defective apical insertion of aquaporin-2 in
the renal collecting duct principal cell. Substitution mutations with exchange
of arginine at codon 137 can cause nephrogenic syndrome of inappropriate
antidiuresis or congenital X-linked nephrogenic diabetes insipidus. We present
a novel mutation in codon 137 within AVPR2 with substitution of glycine for
arginine in male dizygotic twins. Nephrogenic diabetes insipidus was demon-
strated by water deprivation test and resistance to vasopressin administration.
While a similar urine exosome release rate was shown between probands and
controls by western blotting for the marker ALIX, there was a selective
decrease in exosome aquaporin-2 versus aquaporin-1 protein in probands
compared to controls.
Introduction
Water balance is achieved through thirst-stimulated water
intake and regulated water excretion by urine. Renal
water handling is governed by osmolality-regulated release
of the hormone arginine vasopressin (AVP) from the pos-
terior pituitary gland. AVP stimulates urine concentration
by increasing water permeability of renal collecting ducts
through activation of the vasopressin-2 receptor (V2R) in
principal cells. Binding of the ligand initiates a cascade of
events by which cyclic AMP through PKA phosphorylates
aquaporin-2 (AQP2) at multiple sites and promotes inser-
tion into the apical membrane of the cells thereby facili-
tating water permeability and concentration of urine.
Clinical disorders of defective urinary concentration
include central diabetes insipidus with AVP deficiency
and nephrogenic diabetes insipidus (NDI) caused by
inability of the kidneys to respond appropriately to AVP.
Primary forms of NDI may be caused by mutations of
the V2R gene, AVPR2, located on the X-chromosome.
More than 200 mutations have been described comprising
deletions, insertions, nonsense, and missense rearrange-
ments. In the protein sequence, the arginine residue at
position 137 is of major significance since mutations may
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cause constitutive activation of V2R resulting in nephro-
genic syndrome of inappropriate antidiuresis (N-SIAD)
or X-linked nephrogenic diabetes insipidus (NDI) due to
loss of function of the V2R (Feldman et al. 2005; Morin
et al. 2012; Fu et al. 2013). The purpose of this report is
to characterize the phenotype of a family with a novel
mutation not previously described and to test the hypoth-
esis that urine exosomes could serve as a noninvasive
diagnostic tool to reveal altered apical membrane trans-
port protein abundance, notably AQP2.
Case Report
The case concerns dizygotic male Caucasian twins, age
24 years at the time of reporting. Their symptoms were
first noted at 8 months of age with delayed mental and
motor skills and failure to thrive. Abnormal fluid intake
and diuresis were noted along with hypernatremia, serum
hyperosmolality, low urinary osmolality, and hyponatri-
uria. During childhood, water deprivation test was
attempted and arginine vasopressin was administered, but
had unremarkable effects on diuresis and urine osmolality.
At the same time, the mother revealed mild symptoms of
excessive fluid intake and diuresis and the patients were
diagnosed clinically with presumably X-linked NDI. The
patients were treated with thiazide diuretics and unlimited
amounts of fluid, after which they thrived. At age 21 years,
the patients stopped all medication due to adverse effect.
Three years later the patients were seen at nephrology ward
and it was decided to perform a standard diagnostic test
for urine concentration ability and perform a genetic analy-
sis. Pedigree is shown in Figure 1A.
Methods
The examination ran as standard diagnostic procedure at
the Department of Nephrology, Odense University Hospi-
tal. No extra samples or procedures were introduced with
other purpose than diagnosis. It was approved as a diag-
nostic procedure by The Regional Scientific Ethics Com-
mittee for Southern Denmark.
Water deprivation test
Baseline laboratory blood and urine samples were
obtained (Table 1), and water deprivation test followed
by the administration of AVP was carried out under con-
stant medical supervision. Free fluid intake was allowed
until 1 h before the test began. If the sodium level rose
above 150 mmol/L or weight loss increased above 5% of
their weight to time = 0, desmopressin was administered.
During the test, their well-being was monitored continu-
ously and blood pressure, pulse, weight, and urinary out-
put were measured hourly and plasma sodium analyzed
immediately after sampling. Plasma AVP concentration
was measured three times during the test.
Exosome analysis
Urinary exosomes were isolated from three spot urine
samples (100 mL) from each patient. The urine samples
were collected at time 0 h (before water deprivation), 4 h
into the test, and after vasopressin administration. All
urine samples were immediately supplemented with two
protease inhibitor complete tablets (Roche, Mannheim,
Germany) and stored at 80°C until recovery of exo-
somes. The urine samples thawed over night at 4°C and
were then thoroughly vortexed and subsequently cen-
trifuged at 1363 g for 30 min at 4°C. Exosomes were pel-
leted by ultracentrifugation of the supernatant at
220,000 g for 100 min at 4°C. The pellet was resuspended
in 2 9 100 lL resuspension buffer (sucrose: 0.3 mol/L;
imidazole: 25 mmol/L; EDTA–disodium salt: 1 mmol/L;
pH 7.2; complete mini tablet; Roche). The amount of
resuspended pellet from ultracentrifugation used for each
western blot was calculated based on creatinine concen-
tration in the original urine samples (Zachar et al. 2015).
To each sample 10X reducing agent (NuPAGE, Biorad,
Hercules, CA) and 4x LDS sample buffer (NuPAGE, Bio-
rad) were added. The samples were denatured for 5 min
at 95°C. The samples were loaded on a 4–15% tris-HCl
SDS-PAGE gel (Biorad) or a 4–12% Bis-Tris, 10 wells
(Invitrogen, Carlsbad, CA). Separation ran with a con-
stant voltage of 200 V for 40–60 min using 1x TGS (10x
TGS, Tris-glycine-SDS, Biorad) as running buffer or 1x
Mes-buffer (NuPAGE 20x MES SDS running buffer,
Invitrogen). Precision Plus Protein Standard (All Blue,
Biorad) was used as a size marker. The samples were
transferred to a PVDF membrane (0.45 lm pore size,
Immobilon P; Millipore, Billerica, MA) at voltage of 35 V
for 60 min. 1X Transfer buffer (Nupage20X transfer buf-
fer in 10% ethanol) was used as running buffer. Prior to
blotting, the membrane was activated with 99.9% ethanol
for 30 sec, then washed in Milli Q water for 1 min, and
afterward placed in transfer buffer. The membrane was
blocked in 5% skim milk/TBST over night at 4°C or for
1 h at room temperature at a shaking table. The mem-
brane was washed 3 9 10 min in TBST. For visualization,
ECL plus Western Blotting Detection System (Amersham
Bioscience/GE Healthcare Buckinghamshire, UK) was
applied to the membrane for 1 min. An image of the
membrane was made by exposure to X-ray film. The pri-
mary antibodies used were goat anti-AQP2 (1:2000 in 5%
skim milk in TBST buffer; sc-9882, Santa Cruz Biotech-
nology c17, Lot. no. K1711, Santa Cruz Biotechnology,
Dallas, TX), rabbit anti-AQP1 (1:3000; ab-15080, Abcam
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Cambridge, UK), mouse anti-ALIX (1:100 in 5% skim
milk in TBST buffer; 3A9, Monoclonal IgG, Santa Cruz
Biotechnology #sc-53538). Primary antibodies were
detected with HRP-conjugated secondary antibody (Dako,
Glostrup, Denmark) and developed using ECL mixture
(Amersham, Birkerod, Denmark).
Results
Ultrasound examination of the kidneys revealed normal
conditions in sibling A, but sibling B had bilateral
hydronephrosis. Sequencing of the AVPR2 gene with
DNA from leukocytes revealed a hemizygous mutation in
exon 2 of AVPR2 in both patients: AVPR2:c.C840G;
p.R137G. The mother was heterozygous for this mutation
(Fig. 1A). Water deprivation resulted in an increase in
plasma [Na+] that prompted administration of AVP after
4.5 h. For both patients, plasma creatinine, carbamide,
and potassium concentrations did not change and were
within normal range. Water deprivation resulted in
10 mmol/L increase in plasma [Na+] (Fig. 1C), a
~17 mosmol/L increase in plasma osmolality (Fig. 1B),
A B
C D
Figure 1. (A) Pedigree. (B–D) Diagrams show the effect of water deprivation test. (B) Increasing plasma and urine osmolality in response to
water deprivation. (C) Changes in plasma AVP concentrations and plasma sodium concentrations during water deprivation. Both increased
significantly. (D) Diagram shows diuresis and weight; probands displayed continuous high diuresis despite water deprivation and weight loss.
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weight loss of 4 kg (3% of body weight), cumulated urine
output ~4.3 and ~4.1 L (Fig. 1D), an increase in urine
osmolality by 50% from low level (100 mosmol/L) at
baseline, and a four times increase in plasma [AVP]
(Fig. 1C). Sibling A had stable blood pressure (133/
85 mmHg) and heart rate (mean 88/min) during the test.
Sibling B showed variable blood pressure range 98/80 to
140/100 mmHg, and heart rate 72–122 bpm. By
immunoblotting, AQP2 was detectable in urine exosomes
from patients and normohydrated control persons
(Fig. 2A). Despite loading similar amount of creatinine in a
much larger volume of urine from patients onto the gel
before SDS-PAGE separation, AQP2 abundance was lower
for the water-deprived patients compared to the controls
throughout (Fig. 2A). AQP2 protein abundance increased
in both patients with water deprivation (Fig. 2A). By con-
trast, aquaporin-1 (AQP1) abundance was not different
between patients and control persons and did not change
visibly with water deprivation (Fig. 2B). To verify that the
signal derived from exosomes and obtain a measure for
exosome release rate, western blotting for multivesicular
body/exosome marker apoptosis-linked gene-2 interacting
protein (ALIX) was performed. It revealed a single signifi-
cant band with no marked difference in abundance with
water deprivation and between controls and patients which
indicate a roughly similar release rate of exosomes from the
renal tubular epithelium (Fig. 2C). When comparing the
patient samples obtained at the time with highest circulat-
ing AVP with the six healthy water-replete controls, AQP2
abundance was significantly lower (Fig. 2C).
Discussion
The present case presents dizygotic male twins with NDI
characterized by repeated dehydration episodes in early
infancy, polyuria, and polydipsia. We identified a not pre-
viously described X-linked missense mutation in exon 2
of the AVPR2 gene, C840G, which causes the amino acid
shift R137G reflected by decreased AQP2 but not AQP1
in urine exosomes.
Table 1. Clinical characteristics of the probands.
Parameter Patient A Patient B Age-matched control




Heart rate, min 88 98
Serum and plasma studies
Erythrocytes vol. Fr. 0.5 0.48 0.40–0.50
Hemoglobin (g/L) 10.3 10.2 8.3–10.5
Platelets (109/L) 234 220 145–350
Leukocytes (109/L) 7.89 7.8 3.50–8.80
Albumin (g/L) 44 43 36–50
Calcium ion (mmol/L) 1.29 1.25 1.18–1.32
Phosphate (mmol/L) 0.62 0.88 0.71–1.53
Creatinine (lmol/L) 70 76 60–105
Carbamid 3.8 3.8 3.2–8.1
Sodium (mmol/L) 144 142 137–145
Potassium (mmol/L) 3.4 3.1 3.5–4.4
Thyrotropin (103 IU/L) 1.7 3.7 0.30–4.0
Thyroxine (nmol/L) 80 82 60–130
Triiodthyronin (nmol/L) 2.1 2.1 1.3–2.2
Cortisol (nmol/L) 488 635 200–700
Glucose (mmol/L) 5.1 6 –
Alanine transaminase (U/L) 14 19 10–70
Bilirubin (lmol/L) 14 15 5–25
Creatinine kinase (U/L) 32 36 50–400
Lactate dehydrogenase (U/L) 213 187 105–205
Urine studies
Albumin, U (mg/L) <5 <5 <20
Osmolalitet, U (mmol/kg) 90 80 50–1400
Sodium, U (mmol/L) 25 <20 –
Ultrasound, kidney Normal Hydronephrosis
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The water deprivation test confirmed the nephrogenic
cause. There was significant, physiologically appropriate,
increase in plasma AVP concentration, but with little
effect on urine parameters. There was a continuous high
urine output, low urine osmolality, and impaired ability
to increase urine osmolality to normal levels. Addition
of exogenous AVP analog corroborated this observation





Figure 2. Results of western immunoblotting experiments with urine exosomes from probands and controls. A similar amount of creatinine
was loaded into each well and thus a larger absolute volume of urine for the patients compared to controls. In A–C, each lane on the SDS-
PAGE contained: 1, time 0 h; 2, 4 h of WD test; 3, 2 h after AVP administration; 4, time 0 h; 5, 4 h of WD test; 6, 2 h after AVP
administration; 7, healthy control 1; 8, healthy control 2; 9, human kidney cortex pool. (A) Aquaporin-2. Predicted molecular weight: 25 kDa
and glycosylated at 36 kDa. Abundance increased slightly with water deprivation in probands. Abundance was markedly lower in patients
compared to two healthy controls. (B) Immunoblotting of urine exosome fraction for aquaporin-1. Predicted molecular weight: 32 kDa.
Numbering was as above. There was a similar level of AQP1 in exosomes across conditions and in patients and controls. (C) Immunoblotting of
urine exosome fraction for an exosome-specific protein (“ALIX”). A prominent protein that migrated in the range ~100 kDa was detected in
both probands and controls and in human kidney homogenate (predicted size 95 kDa). (D) Western immunoblotting of urine exosome fraction
for aquaporin-2. Exosomes from last collection period in patients were compared to six healthy controls in habitual water status. Volume of
urine loaded was normalized for creatinine content. Patients excreted less AQP2 even after severe dehydration compared to water-replete
persons. The lanes on the SDS-PAGE contained: 1, 4 h of WD test twin A; 2, 4 h of WD test twin B; 3–8, healthy controls; 9, human kidney
cortex pool.
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The novel R137G amino acid substitution is located in
the intracellular part of the receptor at the junction of
the third transmembrane domain and second intracellu-
lar loop. The arginine residue at position 137 in the
protein product of this gene is pivotal for normal func-
tion. Published mutations in this codon reveal opposite
phenotypes. Feldman et al. (2005) described two infants
with missense mutations in AVPR2 exchanging arginine
for leucine or cysteine. The clinical phenotype was inap-
propriate antidiuresis with undetectable AVP in plasma
and increased capacity for cAMP production in cells
with heterologous expression of the mutated AVPR2
compared to wild type. This indicated a constitutively
active V2R in these infants. The condition was named
“nephrogenic syndrome of inappropriate antidiuresis”
(N-SIAD). The activation mutations R137L and R137C
conferred pathological water retention and hypona-
triemia. In contrast, the R137H mutation (Barak et al.
2001) was associated with an NDI phenotype similar to
the present R137G mutation. The R137H mutation led
to a phosphorylated receptor protein that was seques-
tered in intracellular vesicles, even in the absence of
agonist, and therefore an impaired cAMP responsiveness
to AVP. Whether a similar change is associated with
the R137G mutation presented here was not resolved by
the present study (Barak et al. 2001). Impaired cAMP
responsiveness in principal cells would affect AQP2
transcription, translation, stability, and trafficking
(Christensen et al. 1998). Loss-of function mutation in
AVPR2 in patients were associated with lower AQP2
protein in urine as determined by immunblotting (Kot-
nik et al. 2007). Changes in apical membrane abun-
dance of AQP2 are reflected in urine exosomes in vitro
and in experimental animals in vivo (Street et al. 2011).
Exosomes originate from all nephron segments (Pisitkun
et al. 2004; Fang et al. 2013), and the present study
showed that based on an exosome marker protein,
ALIX, patients and controls displayed rather similar
overall release rate of exosomes. The similar abundance
in exosomes between probands and patients of the
proximal tubule-associated AQP1 protein is in accor-
dance with identical membrane association and release
rate despite differences in water status and AVP in
plasma. By contrast, the patients excreted significantly
less exosomal AQP2 protein despite maximal endoge-
nous and exogenous AVP stimulation compared to
water-replete control persons. The measurement of urine
exosome AQP abundance could provide a noninvasive
readout for vasopressin-controlled epithelial events that
may aid phenotypic characterization of rare inherited
transport protein disorders in human patients.
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